Association between tryptophan concentrations and the risk of developing cardiovascular diseases: a systematic review and meta-analysis.

Background: Metabolic regulation of various amino acids have been proven to be effective in preventing cardiovascular disease (CVD). The impact of tryptophan, an essential amino acid, on the risk of developing CVD has not been fully elucidated. Aims: The aim of this meta-analysis was to systematical...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrition & Metabolism Vol. 21; no. 1; pp. 1 - 8
Autores principales: Zhang, Jing, Jiang, Xia, Pang, Bo, Li, Dongyun, Kang, Longfei, Zhou, Tengda, Wang, Boyu, Zheng, Lihua, Zhou, Chuan-min, Zhang, Lei
Formato: meta analysis research systematic review tables/charts Journal Article
Publicado: BioMed Central 10/15/2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=180268516&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 180268516
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17437075
        1CYX
      jtl: Nutrition & Metabolism
      issn: 17437075
      maglogo: N
    pubinfo:
      dt: 10/15/2024
      vid: 21
      iid: 1
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        180268516
        180268516
        180268516
        10.1186/s12986-024-00857-1
        180268516
      ppf: 1
      ppct: 7
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Association between tryptophan concentrations and the risk of developing cardiovascular diseases: a systematic review and meta-analysis.
      aug:
        au:
          Zhang, Jing
          Jiang, Xia
          Pang, Bo
          Li, Dongyun
          Kang, Longfei
          Zhou, Tengda
          Wang, Boyu
          Zheng, Lihua
          Zhou, Chuan-min
          Zhang, Lei
        affil: Department of General Surgery, Department of Vascular Surgery, The First Hospital of Hebei Medical University, Shijiazhuang, China
      sug:
        subj:
          Cardiovascular Diseases Prevention and Control
          Tryptophan Metabolism
          Tryptophan Blood
          Tryptophan Urine
          Cardiovascular Risk Factors
          Biological Markers
          Risk Assessment
          Human
          Male
          Adult
          Middle Age
          Aged
          Aged, 80 and Over
          Systematic Review
          Meta Analysis
          PubMed
          Embase
          Cochrane Library
          Coronary Arteriosclerosis
          Heart Failure
          Peripheral Vascular Diseases
          Confidence Intervals
          Descriptive Statistics
          Funding Source
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Aged, 80 & over
          Male
      ab: Background: Metabolic regulation of various amino acids have been proven to be effective in preventing cardiovascular disease (CVD). The impact of tryptophan, an essential amino acid, on the risk of developing CVD has not been fully elucidated. Aims: The aim of this meta-analysis was to systematically review evidence of the effects of tryptophan on CVD risk. Methods: The PubMed, Embase, Web of Science, Cochrane Library, and China National Knowledge Infrastructure (CNKI) databases were searched to collect relevant trials from inception to August 2024. The means and hazard ratios (HRs) were extracted and pooled. Subgroup analysis was performed to identify pooled effect estimates, and sensitivity analysis was conducted to assess the robustness of the pooled estimates. Results: Data were collected from 34,370 people under follow-up for CVD events in 13 studies, including cohort studies and case-control studies. They were categorized into three groups on the basis of sample type and indicators: the plasma tryptophan level group, the plasma tryptophan CVD hazard group, and the urinary tryptophan CVD hazard group. The CVD included in this study were coronary artery disease, heart failure, and peripheral artery disease. Twelve studies on plasma tryptophan were meta-analyzed. The plasma tryptophan levels in CVD patients were generally lower than those in individuals without CVD (SMD = -8.57, 95%CI (-15.77, -1.37), P = 0.02). Decreased circulating tryptophan levels are associated with cardiovascular disease risk (HR = 0.85, 95%CI (0.78, 0.92), P < 0.00001). Conclusions: Decreased circulating tryptophan levels are associated with an increased risk of CVD events. Intervention in circulating tryptophan levels may be indicated to help prevent CVD.
      pubtype: Academic Journal
      doctype:
        meta analysis
        research
        systematic review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N